✕
Let's Talk
✕

Articles

April 16, 2025

Preparing Clinical Centers for the Growing Demand of Cell and Gene Therapies: Insights from IBTV Panel Discussion

Read More

April 14, 2025

Navigating Rising Clinical‑Trial Costs: Insights from Heather Purvis

Read More

April 9, 2025

Innovation at Risk: Title21’s Jonathan Wofford Weighs in on NIH Funding Cuts

Read More

April 1, 2025

Title21 CEO Tony Pare Shares Insights on the 2025 Cell & Gene Therapy Investment Landscape

Read More

January 14, 2025

The Human Toll: Manual Processes in Cell and Gene Therapy Labs in 2025

Read More

December 16, 2024

Future-Proofing Your CGT Operations: Investing in Software for Long-Term Growth

Read More

November 20, 2024

Calculating the True ROI of Cell and Gene Therapy Software: A Comprehensive Guide

Read More

October 31, 2024

From Chaos to Control: Empowering CGT Lab Technicians to Conquer Inventory Challenges

Read More

September 5, 2024

Software Validation in CGT: Ensuring Quality and Compliance in Cell and Gene Therapy

Read More

See Title21 in Action

Discover how our purpose-built solutions simplify complex workflows and accelerate your path from bench to bedside—schedule your demo today.

Schedule a Demo